Topics

No keywords indexed for this article. Browse by subject →

References
59
[1]
Nagy Z, Esiri MM, Joachim C, Jobst KA, Morris JH, King EM et al. Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12: 182–189. 10.1097/00002093-199809000-00010
[2]
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

John Hardy, Dennis J. Selkoe

Science 2002 10.1126/science.1072994
[3]
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017–3023. 10.1523/jneurosci.21-09-03017.2001
[4]
Palotas A, Kalman J, Palotas M, Juhasz A, Janka Z, Penke B . Fibroblasts and lymphocytes from Alzheimer patients are resistant to beta-amyloid-induced increase in the intracellular calcium concentration. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 971–974. 10.1016/s0278-5846(02)00214-2
[5]
Foster TC, Kumar A . Calcium dysregulation in the aging brain. Neuroscientist 2002; 8: 297–301. 10.1177/107385840200800404
[6]
Heizmann CW, Braun K . Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15: 259–264. 10.1016/0166-2236(92)90067-i
[7]
Baimbridge KG, Celio MR, Rogers JH . Calcium-binding proteins in the nervous system. Trends Neurosci 1992; 15: 303–308. 10.1016/0166-2236(92)90081-i
[8]
Guo Q, Christakos S, Robinson N, Mattson MP . Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc Natl Acad Sci USA 1998; 95: 3227–3232. 10.1073/pnas.95.6.3227
[9]
Wernyj RP, Mattson MP, Christakos S . Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide. Brain Res Mol Brain Res 1999; 64: 69–79. 10.1016/s0169-328x(98)00307-6
[10]
Jung EM, An BS, Choi KC, Jeung EB . Apoptosis- and endoplasmic reticulum stress-related genes were regulated by estrogen and progesterone in the uteri of calbindin-D(9k) and -D(28k) knockout mice. J Cell Biochem 2012; 113: 194–203. 10.1002/jcb.23344
[11]
Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci USA 2003; 100: 9572–9577. 10.1073/pnas.1133381100
[12]
Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth A, Meyer M . Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. Proc Natl Acad Sci USA 1997; 94: 1488–1493. 10.1073/pnas.94.4.1488
[13]
Farre-Castany MA, Schwaller B, Gregory P, Barski J, Mariethoz C, Eriksson JL et al. Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behav Brain Res 2007; 178: 250–261. 10.1016/j.bbr.2007.01.002
[15]
Iritani S, Niizato K, Emson PC . Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease. Neuropathology 2001; 21: 162–167. 10.1046/j.1440-1789.2001.00393.x
[16]
Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY et al. Intracellular amyloid-beta accumulation in calcium-binding protein-deficient neurons leads to amyloid-beta plaque formation in animal model of Alzheimer's disease. J Alzheimer's Dis 2012; 29: 615–628. 10.3233/jad-2011-111778
[17]
Janus C, Westaway D . Transgenic mouse models of Alzheimer's disease. Physiol Behav 2001; 73: 873–886. 10.1016/s0031-9384(01)00524-8
[18]
Kobayashi DT, Chen KS . Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav 2005; 4: 173–196. 10.1111/j.1601-183x.2005.00124.x
[19]
Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR . Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992; 13: 239–250. 10.1016/0169-328x(92)90032-7
[20]
Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfeld RL . Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 1992; 6: 1843–1848.
[21]
The Role of Dynamin-Related Protein 1, a Mediator of Mitochondrial Fission, in Apoptosis

Stephan Frank, Brigitte Gaume, Elke S. Bergmann-Leitner et al.

Developmental Cell 2001 10.1016/s1534-5807(01)00055-7
[22]
Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB et al. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006; 27: 1564–1576. 10.1016/j.neurobiolaging.2005.09.021
[23]
Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD . Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 14670–14675. 10.1073/pnas.0903563106
[24]
Danial NN, Korsmeyer SJ . Cell death: critical control points. Cell 2004; 116: 205–219. 10.1016/s0092-8674(04)00046-7
[25]
Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS . Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287: C817–C833. 10.1152/ajpcell.00139.2004
[26]
Cha MY, Han SH, Son SM, Hong HS, Choi YJ, Byun J et al. Mitochondria-specific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 2012; 7: e34929. 10.1371/journal.pone.0034929
[27]
Blass JP, Sheu RK, Gibson GE . Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci 2000; 903: 204–221. 10.1111/j.1749-6632.2000.tb06370.x
[28]
Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH . Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 2011; 20: 4515–4529. 10.1093/hmg/ddr381
[29]
Ghosh A, Greenberg ME . Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995; 268: 239–247. 10.1126/science.7716515
[30]
Yamin G . NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J Neurosci Res 2009; 87: 1729–1736. 10.1002/jnr.21998
[31]
A synaptic model of memory: long-term potentiation in the hippocampus

T. V. P. Bliss, G. L. Collingridge

Nature 1993 10.1038/361031a0
[32]
Molinari S, Battini R, Ferrari S, Pozzi L, Killcross AS, Robbins TW et al. Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc Natl Acad Sci USA 1996; 93: 8028–8033. 10.1073/pnas.93.15.8028
[33]
Adams JP, Sweatt JD . Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 2002; 42: 135–163. 10.1146/annurev.pharmtox.42.082701.145401
[34]
Shaywitz AJ, Greenberg ME . CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821–861. 10.1146/annurev.biochem.68.1.821
[35]
Pasti L, Carmignoto G, Pozzan T, Battini R, Ferrari S, Lally G et al. Cellular calcium handling in brain slices from calbindin D28k-deficient mice. Neuroreport 1999; 10: 2367–2372. 10.1097/00001756-199908020-00027
[36]
Greene JR, Radenahmad N, Wilcock GK, Neal JW, Pearson RC . Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease. Neuropathol Appl Neurobiol 2001; 27: 339–342. 10.1046/j.0305-1846.2001.00351.x
[37]
Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006; 63: 693–699. 10.1001/archneur.63.5.693
[38]
A Distinct Pathway Remodels Mitochondrial Cristae and Mobilizes Cytochrome c during Apoptosis

Luca Scorrano, Mona Ashiya, Karolyn Buttle et al.

Developmental Cell 2002 10.1016/s1534-5807(01)00116-2
[39]
Youle RJ, Karbowski M . Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 2005; 6: 657–663. 10.1038/nrm1697
[40]
Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T et al. Mitochondrial bioenergetics and structural network organization. J Cell Sci 2007; 120 (Pt 5): 838–848. 10.1242/jcs.03381
[41]
Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol Med 2010; 2: 490–503. 10.1002/emmm.201000102
[42]
Nakanishi S . Molecular diversity of glutamate receptors and implications for brain function. Science 1992; 258: 597–603. 10.1126/science.1329206
[43]
Fukunaga K, Miyamoto E . Role of MAP kinase in neurons. Mol Neurobiol 1998; 16: 79–95. 10.1007/bf02740604
[44]
Bading H, Greenberg ME . Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 1991; 253: 912–914. 10.1126/science.1715095
[45]
Li Z, Okamoto K, Hayashi Y, Sheng M . The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004; 119: 873–887. 10.1016/j.cell.2004.11.003
[46]
Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006; 25: 3900–3911. 10.1038/sj.emboj.7601253
[47]
Pozueta J, Lefort R, Shelanski ML . Synaptic changes in Alzheimer's disease and its models. Neuroscience 2012; 251: 51–65. 10.1016/j.neuroscience.2012.05.050
[48]
Kim JH, Lee JA, Song YM, Park CH, Hwang SJ, Kim YS et al. Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth. FASEB J 2006; 20: 109–111. 10.1096/fj.05-4826fje
[49]
Bellido T, Huening M, Raval-Pandya M, Manolagas SC, Christakos S . Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J Biol Chem 2000; 275: 26328–26332. 10.1074/jbc.m003600200
[50]
D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 2011; 14: 69–76. 10.1038/nn.2709

Showing 50 of 59 references

Cited By
92
Frontiers in Molecular Biosciences
International Journal of Molecular...
Metrics
92
Citations
59
References
Details
Published
May 23, 2014
Vol/Issue
21(10)
Pages
1575-1587
License
View
Cite This Article
S-Y Kook, H Jeong, M J Kang, et al. (2014). Crucial role of calbindin-D28k in the pathogenesis of Alzheimer’s disease mouse model. Cell Death & Differentiation, 21(10), 1575-1587. https://doi.org/10.1038/cdd.2014.67
Related

You May Also Like

Ferroptosis: process and function

Y Xie, W Hou · 2016

3,266 citations

Emerging roles of caspase-3 in apoptosis

Alan G Porter, Reiner U Jänicke · 1999

3,250 citations

Roles of CHOP/GADD153 in endoplasmic reticulum stress

S Oyadomari, M Mori · 2003

2,417 citations